Privacy Policy
Signals Blog

Contributors

Categories

David Kent

Dr. David Kent is a Principal Investigator at the York Biomedical Research Institute (https://www.york.ac.uk/biology/research/infection-immunity/david-kent/). His laboratory's research focuses on the fundamental biology of blood stem cells and how changes in their regulation lead to cancers. David has a long history of public engagement and outreach including the creation of The Black Hole (https://www.universityaffairs.ca/opinion/the-black-hole/) in 2009. He has been writing for Signals since 2010.

Posts by: David


EMC: Theory of regenerativity

Author: David Kent, 10/28/13

> Last Friday was the final day of the Till & McCulloch Meetings in Banff, which was a great display of collaborative stem cell projects going on across the country. I’ll emphasize again how wonderful this meeting is for getting a broad survey of research in adult and pluripotent stem cells without having to wade […]

Day 2 at #TMM2013: Outliers and Rebellious Cells

Author: David Kent, 10/24/13

> Day 2 of TMM2013 began with a video link shared session between this meeting here in Banff and another happening in Leipzig. It was a pretty cool idea and underscores two neat things about the Canadian Stem Cell Network and CCRM. First, despite being viewed as a national stem cell network meeting there is […]

Day 1 at #TMM2013: Hongkui Deng breaks down iPS cells

Author: David Kent, 10/23/13

> Set in the beautiful mountain setting of Banff National Park, the first hours of the Till and McCulloch meeting have not disappointed. Our morning plenary began with an excellent historical perspective from Shin-Ichi Nishikawa on the origins of blood stem cells and rolled on through an excellent series of talks on epigenetic regulation and […]

Preliminary success in blood stem cell gene therapy

Author: David Kent, 08/12/13

. Last month, two studies were published in Science from Luigi Naldini’s group on correcting disease-associated mutations in patient’s stem cells. The two diseases, Wiskott-Aldrich Syndrome (WAS) and Metachromatic Leukodystrophy, are sometimes treated with bone marrow transplantation, which relies on identification of matched donors and risks severe complications through graft vs. host disease and lifelong immunosuppression. Using a patient’s own […]

Dear student: Read the supplementary material

Author: David Kent, 06/27/13

. Last week I was forwarded a Cell Stem Cell article to consider by another Signals blogger entitled, “Dear Student: Stem Cell Scientists’ Advice to the Next Generation.” As a stem cell biologist still in training, I was curious to read what senior established stem cell scientists would feel was most important to tell our […]